VICTORIA UDEALER: Open Payments
NPI 1104336890 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 10 payments from 10 companies in 2025. Trend: 2023 $801 · 2024 $698 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $123 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Ethicon US, LLC | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $76 |
| Alkermes, Inc. | 1 | $72 |
| GlaxoSmithKline, LLC. | 1 | $69 |
| E.R. Squibb & Sons, L.L.C. | 1 | $62 |
| Novo Nordisk Inc | 1 | $62 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
Products named: QULIPTA, RECORLEV, STRATAFIX, JARDIANCE, LYBALVI, NUCALA, Ozempic, LifeVest.
Industry payments across DE — which companies pay providers there.
